Gene Query: RGS16

Dataset Description Geneva Score
Transcriptomic analysis of human tonsillar TFH subsets 122.23
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 96.47
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 96.47
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 91.47
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 82.04
Comparison of microRNA Profiling Platforms (HTS) 71.86
Comparison of microRNA Profiling Platforms 71.86
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 67.48
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 65.06
WRN knockout effects upon gene expression in SW48 and OVK18 57.98
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 57.12
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 57.12
CD95/Fas ligand mRNA is toxic to cells 54.58
Role of COP1 on MAP kinase transcriptional output in melanoma 54.19
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 52.21
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 51.75
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 49.12
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 47.54
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 45.23
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 45.23
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 43.18
Peptidomimetic blockade of MYB in acute myeloid leukemia 43.18
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 42.99
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 42.99
Transcriptome analysis of kidney organoids 41.63
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 41.52
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 41.49
scRNASeq analysis of cycling cardiomyocytes 40.6
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 39.99
RNA-sequencing of human tendon after injury 39.67
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 39.53
Pharmacologic inhibition of STAT5 in AML 38.77
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 38.36
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 37.87
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 37.63
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 37.42
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 36.74
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 36.22
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 35.32
Hypoxic transcriptome of SQ20B human head and neck cancer cells 35.18
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 34.8
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 34.75
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 33.74
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 33.6
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 33.6
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 33.51
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 33.5
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 33.02
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 33.02
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 32.98
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 32.91
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 32.84
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 32.71
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 32.02
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 31.31
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 30.35
Transcriptional effect of ETV1 knockdown in melanoma cells 30.22
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 29.73
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 29.52
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 29.49
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 29.38
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 29.25
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 29.23
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 28.84
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 28.71
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 28.53
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 28.52
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 28.47
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 28.31
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 27.95
The MEF2B Regulatory Network - RNA-seq data 27.94
The MEF2B Regulatory Network 27.94
Identification of global regulators of T-helper cell lineage specification 27.62
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 27.62
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 27.5
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 27.24
Targeting MTHFD2 in Acute Myeloid Leukemia 27.19
Oncogenic MYC induces a dependency on the spliceosome in human cancer 26.85
Morphological and molecular characterization of human dermal lymphatic collectors 26.44
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 26.4
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 26.4
Primary Human B-cell Temporal Response to CD40L Stimulation 26.08
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 25.62
Transcriptome of activated human and mouse MAIT cells 25.33
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 24.93
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 24.84
RNA-seq analysis of control and Myc-induced U2OS cells 24.64
Differential gene expression of human melanoma cells [RNA-seq] 24.54
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 24.54
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 24.31
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 23.8
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 23.8
FOXP1 orchestration of ASD-relevant signaling pathways. 23.6
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 23.41
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 23.34
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 23.14
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 23.09
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 23.09
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 21.96
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 21.44
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 21.34
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 21.28
RNAseq Analysis in glioblastoma cells treated with Mepazine 21.13
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 20.96
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 20.88
Human Treg IFNg/IL-10 subpopulations 20.66
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 20.32
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 19.74
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 19.56
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 19.54
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 19.52
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 19.24
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 19.17
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 18.96
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 18.96
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 18.95
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 18.75
Effect of ILF3 on translation during homeostasis and the antiviral response 18.56
Transcriptome analysis of human lung epithelial cells 18.53
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 18.47
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 17.82
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 17.82
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 17.82
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 17.61
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 17.61
Macrophage Ad5f35 M2 Challenge 17.5
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 17.07
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 17.07
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 17.03
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 16.84
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 15.96
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 15.96
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 15.9
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 15.85
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 15.76
Transcriptome analysis of SKI knock-out in HL60 cells 15.76
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 15.46
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 15.41
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 15.13
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 15.04
PNET animal model: new insights (II) 15.02
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 15.0
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 14.91
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 14.59
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 14.46
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 14.46
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 14.46
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 14.27
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 14.15
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 14.11
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 14.11
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 13.91
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 13.89
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 13.89
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 13.59
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 13.32
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 13.23
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 13.15
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 13.06
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 13.06
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 12.91
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 12.91
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 12.77
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 12.69
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 12.66
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 12.59
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 12.57
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 12.53
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 12.44
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 12.44
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 12.41
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 12.35
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 12.2
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 12.2
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 12.11
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 11.95
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 11.95
CDK12 mediated transcriptional regulation in U2OS cells 11.88
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 11.83
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 11.81
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 11.77
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 11.76
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 11.35
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 11.32
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 11.22
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 11.22
Transcriptomic and gene ontology profiling of the human corneal cell types 11.18
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 11.16
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 11.16
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 11.13
Single-cell analysis of human kidney organoids 11.09
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 10.98
RNA-seq of tumor cells following angiopellosis extravasation 10.69
A single cell reference map for human blood and tissue T cell activation 10.67
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 10.62
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 10.62
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 10.48
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 10.46
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 10.36
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 10.36
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 10.3
ARID1A regulates condensin II distribution and chromosomal partition 10.3
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 10.3
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 10.13
RNA sequencing with KSHV infection and enrichment for circular RNAs 10.06
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 10.04
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 10.04
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 10.01
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 9.91
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 9.85
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 9.85
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 9.83
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 9.83
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 9.82
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 9.61
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 9.55
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 9.49
The cohesin complex prevents Myc-induced replication stress 9.48
The evolution of N6-methyladenosine in primates 9.46
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 9.45
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 9.41
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 9.36
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 9.35
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 9.3
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 9.27
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 9.27
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 9.16
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 9.13
RNA-seq analysis of AML cells in response to ASLAN003 9.13
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 9.09
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 8.96
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 8.93
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 8.88
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 8.88
Gene expression changes after LOC550643 silencing 8.8
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 8.77
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 8.75
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 8.58
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 8.57
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 8.57
iPSC derived motor neuron cultures from C9ORF72 carriers 8.57
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 8.53
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 8.41
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 8.28
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 8.28
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 8.26
Seletive inhibition of CDK9 in DLBCL cell lines 8.21
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 8.21
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 8.18
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 8.14
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 8.14
Microglia innatly develop within cerebral organoids 8.13
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 8.1
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 8.1
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 8.09
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 8.07
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 8.05
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 8.03
Genome-wide chromatin analysis of Ewing sarcoma 8.02
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 8.02
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 8.01
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 7.92
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 7.85
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 7.81
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 7.81
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 7.72
RNA-seq analysis of differentiating human erythroblasts 7.48
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 7.48
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 7.48
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 7.44
NKX2.2 7.44
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 7.43
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 7.41
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 7.41
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 7.39
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 7.38
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 7.37
Targeted enhancer activation by a subunit of the integrator complex 7.36
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 7.23
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 7.21
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 7.21
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 7.2
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 7.18
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 7.18
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 7.17
RNA-seq in endometrial stromal tumors 7.16
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 7.13
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 7.04
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 7.04
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 7.04
The comparison of high-throughput single-cell RNA-seq methods 6.9
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 6.89
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 6.88
Transcriptional profiles of normal human mature B cells 6.86
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 6.83
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 6.75
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 6.74
Stem and effector CD8 T-cells from human cancers 6.71
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 6.71
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 6.68
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 6.65
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 6.63
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 6.62
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 6.62
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 6.6
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 6.59
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 6.59
LIN28A Over-expression RNAseq 6.48
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 6.47
Downregulation of DDX5/DDX17 and REST 6.46
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 6.39
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 6.36
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 6.36
Gene expression profiling of papillary thyroid cancer from central and invasive regions 6.33
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 6.31
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 6.24
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 6.22
NAPRT activation of macrophages 6.21
MCF-7 as a model for functional analysis of breast cancer risk variants 6.15
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 6.08
Macrophage Ad5f35 PhenoMap 6.06
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 6.05
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 6.0
Single-cell analysis of adult human ovary using 10X genomics 6.0
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 5.95
MYC dependent mRNA translation shapes gene expression and cell biology 5.95
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 5.92
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 5.92
Polarized B -cell functions 5.67
Nonpregnant and term pregnant human myometrial tissues 5.66
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 5.66
Next Generation Sequencing of human SMA and healthy control Motor Neurons 5.48
RNA polymerase in pre-B-ALL cell lines 5.48
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 5.47
Total RNA sequencing of APC mutant and wt colonic organoids 5.45
Transcriptional landscape changes during human embryonic stem cell derivation 5.45
Reprogrammed myeloid cell transcriptomes in NSCLC 5.42
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 5.33
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 5.3
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 5.29
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 5.25
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 5.24
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 5.21
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 5.21
Genome-wide mapping of TEL-AML1 targets in acute leukemia 5.1
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 5.09
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 5.04
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 4.91
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 4.8
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 4.74
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 4.61
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 4.6
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 4.53
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 4.51
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 4.49
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 4.49
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 4.43
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 4.43
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 4.41
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 4.39
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 4.36
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 4.35
Zika virus infection reprograms global transcription of host cells to allow sustained infection 4.33
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 4.24
Fibroblasts in cholesteatoma activate osteoclasts. 4.23
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 4.2
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 4.2
RNA-seq of SCLC PDX models treated with EP 4.15
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 4.09
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 3.95
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 3.93
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 3.87
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 3.87
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 3.87
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 3.86
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 3.7
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 3.69
Single cell transcriptome of peritoneal cells 3.66
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 3.57
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 3.54
circNFIB suppresses lymphatic metastasis of pancreatic cancer 3.51
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 3.47
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 3.45
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 3.38
Transcriptional profiling of microglia; current state of the art and future perspectives 3.37
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 3.31
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 3.26
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 3.21
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 3.2
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 3.18
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 3.14
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 3.1
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 3.08
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 2.99
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 2.99
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 2.95
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 2.95
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 2.9
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 2.87
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 2.87
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 2.84
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 2.81
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 2.8
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 2.76
RNA-Seq from human ILC transitional populations 2.74
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 2.74
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 2.73
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 2.73
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 2.71
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 2.7
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 2.7
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 2.67
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 2.66
The expression profiles of GBC liver metastasis 2.58
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 2.53
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 2.47
MAIT cell RNA sequencing 2.47
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 2.43
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 2.42
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 2.41
Differential Protein Occupancy Profiling of the mRNA Transcriptome 2.4
Characterization of the Merkel cell carcinoma miRNome 2.37
Gene expression profile of multiple myeloma cell lines treated with CB-5083 2.35
RNA-Seq of the corpus callosum from 12 individuals 2.34
Epigenome regulation during epidermal lineage commitment [RNA-seq] 2.31
Metastasis in triple-negative breast cancer 2.29
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 2.29
Epigenome regulation during epidermal lineage commitment 2.11
Non-coding regions are the main source of tumor-specific antigens [human] 2.08
Non-coding regions are the main source of tumor-specific antigens 2.08
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 2.07
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 2.06
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 2.06
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 2.05
Transcriptome of human ILC2s; primary vs IL-1b-primed 2.0
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 1.99
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 1.96
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 1.89
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 1.87
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 1.84
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 1.84
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 1.84
A novel target of EZH1/2 for treatment of mantle cell lymphoma 1.77
SF3B1 Degron knockdown RNA-seq 1.77
The Genetic Landscape of Diamond-Blackfan Anemia 1.71
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 1.71
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 1.71
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 1.68
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 1.64
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 1.54
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 1.45
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 1.44
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 1.43
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.41
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 1.4
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 1.34
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 1.33
Interphase condensins regulate ligand-depedent enhancer activation 1.33
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 1.32
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 1.2
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 1.2
CUREfast: Accelerating research with families 1.17
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 1.16
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 1.14
An acquired vulnerability of drug resistant melanoma with therapeutic potential 1.14
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 1.07
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 1.05
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 0.93
Postnatal lipids drive hepatocyte maturation 0.91
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 0.88
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 0.86
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 0.85
Expression profiles of the four human major ectodermal lineages 0.74
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 0.74
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 0.73
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.72
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 0.69
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 0.69
JAK dependent survival of ALK- ALCL 0.69
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 0.69
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.63
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.63
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 0.59
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 0.5
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 0.5
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.48
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 0.41
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 0.41
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.38
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.38
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.34
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.29
STX4 Over-Expression in Human islets 0.29
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.28
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 0.26
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.24
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.24
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.23
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 0.19
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.06


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation